A clinical trial testing the safety and efficacy of an investigational monoclonal antibody for treating people who are hospitalized with respiratory disease and low blood oxygen due to infection with SARS-CoV-2, the virus that causes COVID-19, has begun. The Phase 2 trial, called the COVID-19 anti-CD14 Treatment Trial (CaTT), is sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Covid-19 and clinical trials
The pandemic COVID-19 has created havoc all over the world. It has caused us to rethink everything, including how clinical research is conducted. Clinical researchcourses institutes have completely changed their way of working and processing data and results. The best clinical research course of action has changed drastically and has resulted in new trends in the research world. Clinical trial recruitment has become a challenge due to the global pandemic as people are socially distanced from one another. However, they have stayed connected through social media platforms. The benefit of reaching patients online or digitally is that they can be reached from any part of the world. Digital platforms make it easier to reach out to people, and it also encourages active participation in clinical trials. The latest trends in clinical trial recruitments include increased use of digital advertising to find the most suited patients for a trial.
The most commonly asked question by the volunteers of any clinical trial recruitment process is the protection given to them. There are a number of measures that are taken to ensure that the participants of the trial are well protected and safe during the trial. The concerned authorities constantly review the protocols of every trial to ensure that it is done ethically and the patients' rights are protected. Apart from this, the FDA provides oversight for clinical trial testing of medical devices or drugs. Prior to human clinical trials, the FDA reviews the applications for the new treatments and medications to ensure that the studies and researches have protections in place for the volunteers. The completely informed consent forms of the patients are one of the most important pieces of the puzzle of any clinical trial that protects the volunteers. Any changes in the mind of the volunteers enable them to withdraw from the trail immediately, ensuring their complete safety.
Clinical research trainings are given to every professional involved in the trial. Clinical research courses are continuously updated based on the disease and development of technology to ensure the complete safety of the participants of the trial.